EverSource Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
EverSource Wealth Advisors's FLNA Position: Q3 2026 in Review
EverSource Wealth Advisors held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 425 shares worth $377. The position accounts for ﹤0.01% of the portfolio, ranked #4234.
EverSource Wealth Advisors first reported a position in FLNA in Q4 2021 and has held it in 20 quarters since. The position peaked at $11K in Q3 2025. 28 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.
- EverSource Wealth Advisors held 425 shares of Filana Therapeutics worth $377 as of Q3 2026.
- EverSource Wealth Advisors left its Filana Therapeutics share count unchanged in Q3 2026.
- Filana Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4234 holding.
- EverSource Wealth Advisors first reported a position in Filana Therapeutics in Q4 2021 and has held it in 20 quarters since.
- EverSource Wealth Advisors's Filana Therapeutics position peaked at $11K in Q3 2025.
- 28 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.